Lectenz® Bio receives patent issuance from USPTO

The Lectenz® Bio team is excited to announce the approval of its patent for the Lectenz® platform technology.

This paves the way for more research and development for both Lectenz® and GlycoSense products.

 

More about the patent: 

Glycan-Specific Analytical Tools. U.S. Patent Number 9,926,612 B2. This patent is for core aspects and embodiments of the Lectenz® development platform. (Patent issued by USPTO March 27, 2018.)